Author(s) McDonagh, P.Reed; Sundaresan, G.; Yang, L.; Sun, M.; Mikkelsen, R.; Zweit, J.
Journal Nanomedicine
Date Published 2018 Apr 08

Cerium oxide nanoparticles (CONPs) have unique surface chemistry allowing catalyst-like antioxidant properties, and are being investigated for several disease indications in medicine. Studies have utilized surface modified CONPs toward this application, but have been lacking in comprehensive biodistribution and pharmacokinetic data and a direct comparison to uncoated CONPs. We developed an enhanced single-pot synthesis of several coated CONPs and an efficient intrinsic core labeling of CONPs with the clinical PET isotope, zirconium-89, allowing detailed PET imaging and ex vivo biodistribution. All coated [Zr]-CONPs showed benefit in terms of biodistribution compared to uncoated [Zr]-CONPs, while retaining the intrinsic antioxidant properties. Among these, poly(acrylic acid) coated CONPs demonstrated excellent candidacy for clinical implementation due to their enhanced renal clearance and low reticuloendothelial system uptake. This work also demonstrates the value of intrinsic core labeling and PET imaging for evaluation of nanoparticle constructs to better inform future studies towards clinical use.

DOI 10.1016/j.nano.2018.04.002
ISSN 1549-9642
Citation Nanomedicine. 2018.

Related Applications, Forms & Industries